• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[接受重复血液透析治疗的慢性肾病患者甲状旁腺激素的CIP和CAP片段及钙磷平衡的选定参数]

[CIP and CAP fragments of parathormone and selected parameters of calcium-phosphate balance in patients with chronic kidney disease treated with repeated haemodialysis].

作者信息

Polak-Jonkisz Dorota, Zwolińska Danuta, Nahaczewska Wiesława

机构信息

Katedra i Klinika Nefrologii Pediatrycznej Akademii Medycznej we Wroclawiu.

出版信息

Pediatr Endocrinol Diabetes Metab. 2010;16(1):25-8.

PMID:20529602
Abstract

INTRODUCTION

Chronic kidney disease (CKD) leads to bone and mineral complications, which are manifested, among others, by hyperparathyroidism, calcium-phosphate and vitamin D balance disturbances. The results of investigation assessing the usefulness of CAP/CIP ratio, (cyclase activating PTH/cyclase inactive PTH) as a marker of bone turnover and bone disturbances in this group of patients are contradictory.

AIM OF THE STUDY

was to estimate the concentration of CAP and CIP of parathormone, connection with selected calcium-phosphate balance parameters and usefulness of CAP/CIP ratio to differentiate bone mineral density in patients with CKD treated with repeated haemodialysis.

MATERIAL AND METHODS

The study included 31 children aged 5 to 18 years. Group I - 15 haemodialysed children. Group II - 16 healthy children. The patients underwent the following serum measurements: calcium concentration (Ca), inorganic phosphate (P), 1.25-dihydroxyvitamin D, parathormone (intact PTH), and CAP, CIP were evaluated with Scantibodies Laboratory Inc test. In group I the densitometric examination was done using the Lunar DPX-L system, performing the overall bone measurement.

RESULTS

In children from group I the average values of iPTH concentration and both CIP and CAP components were significantly elevated (p<0.05) as compared to group II. CAP/CIP ratio in group I was <1; in healthy children >1. Average concentrations of Ca and 1.25(OH)2D in serum of group I were lowered, although without statistical significance in comparison with group II. CAP/CIP ratio does not differentiate the children with bone disturbances. Densitometric examination revealed osteopenic changes in 3 children and osteoporosis in 2 children. There were no statistically significant correlations between the examined parameters.

CONCLUSIONS

  1. The CIP/CAP ratio does not differentiate the bone mineral density status and it is not associated with biochemical parameters of calcium-phosphate metabolism. 2. This indicates its poor diagnostic utility with reference to mineralization disturbances in children with chronic kidney disease.
摘要

引言

慢性肾脏病(CKD)会导致骨与矿物质并发症,其中表现为甲状旁腺功能亢进、钙磷及维生素D平衡紊乱。评估环化酶激活型甲状旁腺激素/环化酶失活型甲状旁腺激素(CAP/CIP)比值作为该组患者骨转换和骨紊乱标志物的研究结果相互矛盾。

研究目的

旨在评估甲状旁腺激素的CAP和CIP浓度,与选定的钙磷平衡参数的关系,以及CAP/CIP比值在接受重复血液透析治疗的CKD患者中区分骨密度的效用。

材料与方法

该研究纳入了31名5至18岁的儿童。第一组 - 15名接受血液透析的儿童。第二组 - 16名健康儿童。患者接受了以下血清检测:钙浓度(Ca)、无机磷(P)、1,25 - 二羟维生素D、甲状旁腺激素(完整PTH),并使用Scantibodies Laboratory Inc检测评估CAP和CIP。在第一组中,使用Lunar DPX - L系统进行骨密度检查,进行全身骨测量。

结果

与第二组相比,第一组儿童的iPTH浓度以及CIP和CAP成分的平均值均显著升高(p<0.05)。第一组的CAP/CIP比值<1;健康儿童>1。第一组血清中Ca和1,25(OH)2D的平均浓度降低,尽管与第二组相比无统计学意义。CAP/CIP比值无法区分有骨紊乱的儿童。骨密度检查显示3名儿童有骨质减少变化,2名儿童有骨质疏松。所检测参数之间无统计学显著相关性。

结论

  1. CIP/CAP比值无法区分骨密度状态,且与钙磷代谢的生化参数无关。2. 这表明其在诊断慢性肾脏病儿童矿化紊乱方面的效用较差。

相似文献

1
[CIP and CAP fragments of parathormone and selected parameters of calcium-phosphate balance in patients with chronic kidney disease treated with repeated haemodialysis].[接受重复血液透析治疗的慢性肾病患者甲状旁腺激素的CIP和CAP片段及钙磷平衡的选定参数]
Pediatr Endocrinol Diabetes Metab. 2010;16(1):25-8.
2
Ratio of cyclase activating and cyclase inactive parathormone (CAP/CIP) in dialysis patients: correlations with other markers of bone disease.透析患者中环化酶激活型与环化酶失活型甲状旁腺激素的比例(CAP/CIP):与其他骨病标志物的相关性
Rocz Akad Med Bialymst. 2004;49:190-2.
3
The role of cyclase activating (CAP) and cyclase inhibiting (CIP) parathormone fractions in the assessment of bone metabolism disturbances in women with hyperprolactinemia of various origin.环化酶激活(CAP)和环化酶抑制(CIP)甲状旁腺激素组分在评估不同病因高催乳素血症女性骨代谢紊乱中的作用。
Neuro Endocrinol Lett. 2008 Feb;29(1):178-84.
4
[Intact whole bioactive parathormone: problems arising from comparing different methods].[完整的具有生物活性的甲状旁腺激素:比较不同方法时出现的问题]
G Ital Nefrol. 2002 Jul-Aug;19(4):467-75.
5
Measurement of PTH fragments for assessment of renal bone disease in hemodialysis patients.检测甲状旁腺激素片段以评估血液透析患者的肾性骨病
Kidney Blood Press Res. 2006;29(3):175-81. doi: 10.1159/000095351. Epub 2006 Aug 24.
6
1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.1α(OH)D3 一α-羟基胆钙化醇——一种活性维生素 D 类似物。关于慢性透析的尿毒症患者继发性甲状旁腺功能亢进症预防和治疗的临床研究。
Dan Med Bull. 2008 Nov;55(4):186-210.
7
[Treatment of mineral bone disorder with pharmaceuticals which influence the calcium phosphor turnover].用影响钙磷代谢的药物治疗矿物质骨病
Ugeskr Laeger. 2012 Nov 19;174(47):2931-4.
8
Serum level of intact parathyroid hormone and other markers of bone metabolism in dialyzed patients.透析患者血清中完整甲状旁腺激素水平及其他骨代谢标志物
Adv Perit Dial. 2007;23:162-5.
9
The assay of the hypocalcemic PTH fragment inhibitor with PTH provides a more accurate assessment of renal osteodystrophy compared to the intact PTH assay.与完整甲状旁腺激素(PTH)检测相比,使用PTH检测低钙血症性PTH片段抑制剂能更准确地评估肾性骨营养不良。
Nefrologia. 2003;23 Suppl 2:69-72.
10
[Serum osteocalcin in children with chronic renal insufficiency].[慢性肾功能不全患儿的血清骨钙素]
Srp Arh Celok Lek. 1996 Sep-Oct;124(9-10):227-31.